Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Accolade Inc (NQ: ACCD )

3.700 -0.010 (-0.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Accolade Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Why Is Accolade (ACCD) Stock Up Today?
Today, investors in Accolade and ACCD stock have something to cheer, following a rather dismal end to last week. 
Via InvestorPlace
Mid-Afternoon Market Update: Nasdaq Gains 100 Points; First Wave BioPharma Shares Plunge
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 100 points on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Mid-Day Market Update: Dow Drops Over 100 Points; Hilltop Holdings Shares Spike Higher
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping more than 100 points on Monday. 
Via Benzinga
31 Stocks Moving In Monday's Mid-Day Session
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) climbed 64.9% to $9.86. Redbox recently reported CFO transition. SoundHound AI, Inc. (NASDAQ: SOUN) shares gained 30.5% to $8.48... 
Via Benzinga
Why Are Accolade Shares Down Over 40% Today
Via Benzinga
Analyzing Accolade's Short Interest
Accolade's (NASDAQ:ACCD) short percent of float has fallen 9.9% since its last report. The company recently reported that it has 4.30 million shares sold short, which is 7.74% of... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
Upgrades 
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Expert Ratings for Accolade
Within the last quarter, Accolade (NASDAQ:ACCD) has observed the following analyst ratings: 
Via Benzinga
70 Biggest Movers From Friday
Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)... 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
ACCD EQUITY ALERT: Rosen Law Firm Encourages Accolade, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – ACCD
From Rosen Law Firm
Via Business Wire
Mid-Afternoon Market Update: Nasdaq Down 3%; Accolade Shares Slide
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite tumbling around 3% on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Mid-Day Market Update: Dow Dips 500 Points; GTY Technology Holdings Shares Jump
U.S. stocks extended losses midway through trading, with the Dow Jones dropping around 500 points on Friday. 
Via Benzinga
48 Stocks Moving In Friday's Mid-Day Session
Gainers Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ADS. GTY Technology Holdings Inc. (NASDAQ:... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022
Upgrades 
Via Benzinga
Mid-Morning Market Update: Markets Down; Nasdaq Falls 100 Points
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! It's the beginning of the end as we break down all of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
28 Stocks Moving in Friday's Pre-Market Session
Gainers Zymeworks Inc. (NASDAQ: ZYME) rose 40.3% to $6.97 in pre-market trading. Zymeworks 13D filing confirmed earlier reporting of offer letter from Blue Falcons for $10.50 per... 
Via Benzinga
74 Biggest Movers From Yesterday
Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Accolade
Accolade (NASDAQ:ACCD) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 3... 
Via Benzinga
48 Stocks Moving In Thursday's Mid-Day Session
Gainers T Stamp Inc. (NASDAQ: IDAI) shares jumped 201% to $6.33. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric MFATM) solution. Statera... 
Via Benzinga
Analyst Ratings For Accolade
Over the past 3 months, 5 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Enveric Biosciences (NASDAQ:ENVB)... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022
Upgrades 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.